Estrogen's Heart Protection in Ovariectomized Rats
Author Information
Author(s): Gowayed Mennatallah A., Zakaraya Zainab Zaki, Abu-Samra Nehal, Elhamammy Reem H., Abdel Moneim Lobna M., Hafez Hala A., Moneam Ihab A., Oriquat Ghaleb A., Kamel Maher A.
Primary Institution: Pharos University in Alexandria, Alexandria, Egypt
Hypothesis
This study aimed to investigate the estrogen receptor and non-receptor mediated effects of E2 treatment on the cardiac expression of AMPK and mitochondrial homeostasis in ovariectomized rats.
Conclusion
Estrogen treatment has cardioprotective effects in ovariectomized females by modulating cardiac mitochondrial homeostasis and restoring the AMPK signaling pathway.
Supporting Evidence
- Estrogen deficiency leads to increased cardiovascular disease risk.
- E2 treatment corrected lipid profiles in ovariectomized rats.
- Fulvestrant blocked the cardioprotective effects of E2.
- E2 administration normalized cardiac autophagy and mitochondrial dynamics.
- AMPK signaling was restored with E2 treatment.
Takeaway
When female rats had their ovaries removed, they had heart problems, but giving them estrogen helped fix those problems.
Methodology
Female Wistar rats were divided into sham and ovariectomized groups, treated with either E2, Fulvestrant, or a combination for 28 days, and various cardiac parameters were measured.
Potential Biases
Potential bias in the selection of treatment groups and the interpretation of results.
Limitations
The study was conducted on rats, which may not fully represent human physiology.
Participant Demographics
Sixty-four female Wistar rats aged 8 weeks, weighing 200-220 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website